chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had infection in lower intestine, the infection lasted about a week. I was treated with antibiotics - 1st time ever having an infection in intestines. I went to the ER and waited for 8HRS which they were very busy and never treated me. I went to a gastro MD who referred me to my GP who prescribed the medication. I ran fever and had symptoms and pain at first, I thought it was a kidney stone but ended up being an infection. My GP did order a CT Scan that?s how the infection was located. Symptoms resolved after a week.
Pt was brought by wheelchair from Covid Vaccine clinic where rapid response was called; pt reports 2nd dose pfizer vaccine given; after obtaining chart pt reports "feeling flushed, and then redness/rash on chest, and blood pressure go up". Pt given epi during rapid response;  Pt reported a headache at this time.    Pt denies dizziness, nausea, diarrhea, sob, no facial swelling, no lip swelling; no dysphagia;  RR equal non-labored; Alert and orientated x4;
Dizziness, Headache, Diarrhea, nausea/vomiting, chills, sore throat from vomiting,chills, sore throat from vomiting  Narrative:
Client went to the ER with a fever on 7/12/2019. Ears and throat WNL. Client did have a diaper rash.
Dyspnea, fever, sinusitis, nausea, loss of appetite. Pt is a 63yo female w h/o dmII, Hypothyroid, obesity, pulm htn COPD on home O2 (2-3L) presented with acute on chronic respiratory distress hypercapnic/hypoventilation evolving over appx 1 week after rec'ing flu vaccination with associated myalgia, cough productive of greyish sputum and subjective mild fever initial ABG with PCO2 of 98. Pt admitted to MICU where she responded well Bipap, nebs, and steroids w/ABGs normalizing to her baseline PCO2 in the low 80s. She did at times require anxiolytics while on Bipap. Pt also underwent CTA to rule out PE. Patient transferred to floor and improved on duonebs/mometasone/formoterol/tiotropium regimen, as well as a steroid taper.
Burning pain in legs & feet. Heart palpitations heart pulse 180 210 when palpitations happened 3 times diagnosis with peripheral neuropathy LYRICA - prescribed - neurologist - CYMBALTA 30 mg NEURONTIN 300 mg effects still felt.
flu like symptoms; diarrhea; severe/bad headache; nausea; This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection; lot number: EL9261; expiry date: unknown) at the age of 75 years old, via an unspecified route of administration in the right arm, on 23Jan2021 09:00, at a single dose, for COVID -19 immunization. The patient had no relevant medical history and was not taking concomitant medications. Patient reported that she got the Pfizer Covid vaccine shot on 23Jan2021 at 9:00. On 24Jan2021, about 2:00, the next morning, she felt like she got hit by a bus further described as flu like symptoms including nausea, diarrhea, and a severe/ bad headache. The events were treated with Phenergan at home. These symptoms lasted about a day; patient completely recovered on 25Jan2021.
On 10/24/2022, I woke up at 01:40AM with heart palpitations. They felt very extreme, like fish flopping around in my chest. I checked my radio pulse, and it was very faint. I waited for a bit to see if it would go away. I woke my husband up ten minutes later. He checked my pulse for a few minutes and suggested that we go to the emergency room. After getting around, my pulse felt more regular, so we decided to hold off. I called my doctor who wanted me to be checked out and advised that I go to an urgent care sense I couldn't be seen with her that day. At urgent care, they performed and EKG and advised that I go to the emergency room based on changes from a previous EKG. At the emergency room they monitored me for 2 hours. The emergency room physician looked at my EKG and said that he didn't see the evidence that they saw at the urgent care and thought I was fine. However, in the written charts that were read by the cardiologist, it states that the changes in the EKG were consistent with what they said at urgent care. I will be following up with my doctor in the near future. They also advised that I have a halter monitor and an echocardiogram to address the heart palpitations because they lasted at least 30 minutes.
Nerve tingling on extremities that was very sporadic, which continued for 16 days on and off.  On November 18th, 2021, noticed Fibromyalgia-like pains throughout body sporadically again.  By November 18th, 2021  the pains subsided a little.
Reported on 12 Nov 05-Sore throat, fever, headache, myalgias, diarrhea, cough, diarrhea, fatigue.
Information has been received from a physician concerning a 15-year-old male with no pertinent medical history who on approximately 15-SEP-2005 was vaccinated with a dose of varicella virus vaccine live. On approximately 22-SEP-2005, 7 days post vaccination, the patient developed a varicella-like rash on his arms and legs. The lesions were vesicular in nature and no fever was present. It was reported that the patient recovered. Unspecified  medical attention was sought. There was no product quality complaint. Additional information has been requested.
flap tear; sore arm; This case was reported by a other health professional via call center representative and described the occurrence of injection site injury in a 37-year-old male patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2019-2020 season) (batch number YH595, expiry date 12th June 2020) for prophylaxis.   On 18th October 2019, the patient received FluLaval Quadrivalent 2019-2020 season .5 ml. On 18th October 2019, less than a day after receiving FluLaval Quadrivalent 2019-2020 season, the patient experienced injection site injury and pain in arm. On an unknown date, the outcome of the injection site injury and pain in arm were not recovered/not resolved.   It was unknown if the reporter considered the injection site injury and pain in arm to be related to FluLaval Quadrivalent 2019-2020 season.  Additional details were provided as follows:  Post vaccination the patient experienced a sore left arm. The soreness progressed and the patient was seen by an orthopedic doctor on 05th November 2019 who diagnosed a flap tear. The patient was not able to lift his children due to the pain. The reporter consented to follow up.
Marked worsening of existing tinnitus. Previously, minor tinnitus occurred occasionally in my R ear and was gone within about 60 sec. Frequency was several times a week. After vaccination, tinnitus is very loud, continuous (24/7), and mostly in my L ear. Of course, I cannot conclusively connect this to vaccination, but in checking my diaries, emails, and online forum posts, I find mentions of my tinnitus's worsening from early March, 2021, onward -- i.e., immediately following my first COVID19 vaccination.  Second COVID vaccination give 3/28/2021, Moderna lot # 028A21A.
Fast Racing heart beat. Heart was Pounding in chest. Felt like I couldn?t breathe.  Felt like a weight was on chest. Pain in left arm and hand was cold. Next morning had a slight issue with breathing in the morning but went away.
Started itching 2 or 3 hrs after shot. Called dr. Started taking BENADRYL. Itching kept get worse. Face was bright red. By the 3rd night my face was swollen and had trouble breathing. Went to ER at 3:00 a.m. on Jan 2. Blood pressure was 200/93.
Patient felt tingling/ heaviness in both arms 10 minutes after receiving the vaccine. On site EMS was called vitals BP 135/85 HR 88 100% O2 She was monitered for 20 minutes and  released to go home.
No additional AE details provided; expired dose of MMR II was given to 15 month old patient; This spontaneous report was received from a medical assistant and refers to a 15-month-old patient of unknown gender. The patient's medical history and concurrent conditions were not reported. Concomitant medication included sterile diluent (lot number U026364 was confirmed to be valid, expiration date: 08-NOV-2023).  On 13-JUN-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (rHA) subcutaneous injection, lot number T016197, expiration date: 11-MAY-2022 (dose, strength, and route of administration were not provided) for prophylaxis (expired product administered). The medical assistant stated that both measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and sterile diluent were stored according to prescribing information through date of administration. No additional adverse event was reported (no adverse event).
Information has been received from a nurse concerning a 15 year old female who on 01-OCT-2008 was vaccinated with GARDASIL. There was no concomitant medication. Subsequently, the patient had an injection site reaction "later in the day" following vaccination with GARDASIL that lasted for 24 to 48 hrs. The injection site reaction was described as painful, red injection site. Subsequently, the patient developed a severe headache with aura and felt "dazed" with syncope for about 20 minutes on 08-OCT-2008. The patient had a sore throat and flu like symptoms earlier in the day on 08-OCT-2008, outcome of visit was unspecified.
Patient due for Covid vaccine adult dose and lower dose given (5-11 yr). Dr. informed of the incident. pharmacy was contacted by Dr. to see the follow up or actions we need it to take. Per pharmacist patient doesn't need to complete the full dose. father informed of the incident and he verbalized understanding.
sore arm; general malaise; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (167798). The reporter is the patient.  A 70 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset 2021, outcome "recovered" (2021), described as "sore arm"; MALAISE (non-serious) with onset 2021, outcome "recovered" (2021), described as "general malaise".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recv vax 29AUG95 & 29AUG95 pt exp nausea & lightheadedness;no further details were provided;
This spontaneous report as received from a nurse (L.V.N) refers to a 12 month old patient. On 05-JUL-2013 the patient was inadvertently vaccinated with a dose of PNEUMOVAX23 (Lot#, dose and route not reported). Staff error only. No adverse effects were reported. It was not known if the patient sought medical attention. Additional information is not expected.
This case was reported by a consumer via call center representative and described the occurrence of cognitive impairment in a female patient who received Shingrix for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced cognitive impairment, feeling hot, nausea, headache, tiredness, light headedness, feeling cold and vomiting. On an unknown date, the outcome of the cognitive impairment, feeling hot, nausea, headache, tiredness, light headedness, feeling cold and vomiting were not recovered/not resolved. It was unknown if the reporter considered the cognitive impairment, feeling hot, nausea, headache, tiredness, light headedness, feeling cold and vomiting to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. The patient inquired how long did the side effects last with Shingrix. The patient was feeling hot, cold, nausea, headache, tired, lightheadedness and vomiting since past two days of getting the Shingrix vaccine. The patient was given medical disclaimer and was provided information from content in regards to how long the side effects lasted. The patient was angry and did not want to provide any information and disconnected the call before any questions from the template could be asked.
Titers drawn for pre-placement showing inadequate immunity to Hepatitis B and Mumps. Advised to have booster doses of both, patient consented and provided with VIS which were read by patient and reviewed in detail prior to administration. Hepatitis B administered IM in left deltoid first, MMR administered SQ left posterior arm. After administration of both vaccines, patient was aox3, conversant, BP 117/85. Conversation continued with patient when suddenly he began to feel dizzy. He took a sip of water and became pale, diaphoretic. His hand was shaky and he seemed unsteady. His eyes were open but he maintained a distant gaze. He continued to be responsive non-verbally with hand cues to questions and remained in this state for approximately 3-5 minutes. An ice pack was applied to his neck and his immediate safety was maintained. He started to "come to" and his BP was measured as high 60s SBP. He continued to feel woozy but was verbally responsive at this point and able to drink water. His color began to return and he was more alert and responsive. We transferred him to the exam table where he was fully alert and BP was rechecked as 117/80. His wife came and he left ambulatory with steady gait accompanied by her.
Within a couple hours, I felt very tired.  At about 9pm, I went to bed and started experiencing chills, sweating, intense body aches and pains, a headache, nausea and abdominal pain.  This lasted thru the night.  When I woke up, the chills, sweating and intense body aches and pains were less in severity.  I took my temperature and it was 101.  The temperature was elevated on and off for the next two days.  The other symptoms lessened.  The abdominal pain remained.  I continued to have a headache for over one week.  On the 14th (five days after) I felt like I was finally getting better.  However, on the night of the 14th, the fever returned and the abdominal pain worsened.  I made an appointment with my PCP on the 15th.  I was still experiencing a fever, tiredness, body aches and pain, nausea and abdominal pain.  I also had loose stools.  My PCP requested I be tested for COVID (came back negative) and treated me with antibiotics for diverticulitis.  I finished the treatment and shortly after started experiencing issues with a tooth where I had a root canal several years ago.  I am still experiencing issues with the tooth and am taking amoxicillin.  I have not felt well since the injection on the 9th.  I feel tired, do not have the energy that I would expect to have and still have this nagging tooth issue.  I'm 100% convinced this is all related to the vaccine on the 9th.
HCP was not sure were the subcutaneous area of the patient ended; HCP mentioned they've used a 5/8 needle on the patient instead of a 1 inch needle; This case was reported by a nurse via call center representative and described the occurrence of intramuscular formulation administered by other route in a 54-year-old male patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2021-2022 season) (batch number 95K95, expiry date 30th June 2022) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 20th September 2021, the patient received Fluarix Quadrivalent 2021-2022 season (subcutaneous) and Fluarix Tetra Pre-Filled Syringe Device. On 20th September 2021, unknown after receiving Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced intramuscular formulation administered by other route and wrong technique in device usage process. On an unknown date, the outcome of the intramuscular formulation administered by other route and wrong technique in device usage process were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The nurse reported that the patient with a very substantial deltoid was administered Fluarix vaccine with a 5/8 needle on the patient instead of a 1 inch needle, which led to wrong technique in device usage process. Health care professional was not sure were the subcutaneous area of the patient ended, which led to intramuscular formulation administered by other route. No adverse effects were reported at the time of the reporting. The reporter consented to follow up either by email or phone. No further details were provided. Note: The event intramuscular formulation administered by other route was captured conservatively considering vaccine been administered subcutaneously.
focal sz then gen sz which have been uncontrolled on 4 anticonvulsants
Patient received her second dose of  COVID-19 Moderna vaccine too early.  First dose administered on 26 JUL 21, and second dose administered on 13 AUG 21. both are COVID-19 Moderna vaccines.
Probable Covid Vaccine Arm. Itching and redness appeared 8 days following vaccination. Began yesterday, 2 February and continues.
Patient reports that he has a history of fainting when receiving vaccinations or having blood drawn.  Patient became pale and exhibited decreased consciousness approximately one minute after receiving the COVID-19 Moderna vaccine. He did not lose consciousness. Patient was lowered to a cot and and reported feeling better within 60 seconds of laying down on the cot. EMS on site on standby and assessed patient. Vitals as follows: 3:36 pm: Blood Pressure: 124/74, heart rate:72, oxygen saturation: 99% on room air. 3:38 pm: Blood Pressure: 131/78, heart rate:74, oxygen saturation: 98% on room air. Patient was able to sit up and ambulate without any feelings of dizziness or lightheadedness.  Patient stayed at vaccination clinic until 4:00pm and continued to deny any feelings of dizziness or lightheadedness.Patient also drank a juice box while in the waiting area. Upon leaving vaccination clinic patient was alert and orientated and denied any feelings of dizziness or lightheadedness.  He was amubulatory upon leaving the vaccination clinic.
w/in 1 hrs of receiving vax, pt began vomiting, inc temp by 230AM 30MAR92 p/sponge bath, t104.0; pt seen by MD AM of 20MAR92 who felt it was a rxn to the vax; no tx but cont APAP; temp late PM 20MAR92 was 101, then able to keep fluids down;
Patient waited 15 minutes after the vaccine. She left and went to her doctors appointment. At that time (30 minutes after vaccine), she started to have shortness of breath. She had this for 3-4 days total and then it went away. She had to have the doctor office bring her a wheelchair as the shortness of breath was very severe.
PATIENT HAD DIZZINESS AND LUMPS UNDER HIS LEFT ARM  DAY AFTER HE GOT 2ND DOSE OF COVID*19 SHOT. HE MADE AN APPOINTMENT TO SEE HIS DOCTOR. HE CAME TO PHARMACY AND TALKED TO PHARMACIST, HE WAS TOLD BY PHARMACIST TO TAKE TYLENOL IF NEEDED AND KEEP HIS APPOINTMENT WITH HIS MD
Right eye became sore underneath and a little puffy on Thursday morning, 9/30/21. Friday morning (10/1/21) woke up and eye was nearly swollen shut. Has increased tear production, both under and over eye are swollen. No redness around area.
Employee received 2nd dose of  Pfizer COVID19 vaccine at 1:00 pm on 3/17/2021 and 10 minutes after receiving the vaccine  she developed skin rashes to her right forearm, left lower neck and left hand. She complained of itching to her left hand. She was escorted to the ER where she received treatment.
PATIENT RECEIVED FLUMIST ON 10/13/2008.  DEVELOPED FACIAL NERVE PALSY (BELL'S PALSY) ON 10/21/2008.  12/2/08 Reviewed PCP medical records of 10/4-10/13/08. FINAL DX: none provided Records reveal pt seen 10/4 for removal of sutures from right leg laceration.  Received flumist on 10/13.  1/21/09 Reviewed PCP medical record of 10/22/08. FINAL DX: Bell's palsy Records reveal patient experienced right facial paresis, unable to completely close right eye, eye watery. Tx w/eye protection, no meds.
Pt. states that after receiving the 3rd dose of Moderna 11/06/2021, started experiencing symptoms 11/07/2021 of swelling in the left arm (Cellulitis). Primary visit 11/09/2021, recommendation for Follow-Up of Prednisone.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 02-JUN-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # L040178, expiration date 18-AUG-2017). This specified lot number vaccine was exposed to temperature excursion one time. The total cumulative excursion time was 48 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse event was reported. This is one of several reports received from the same source. Additional information has been requested.
This is a spontaneous report from a contactable nurse via a Pfizer sales representative. A female patient of an unspecified age received TRUMENBA; (lot number unknown), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced forgetfulness occurring about 1 week after vaccination on an unspecified date after the use of the product. The outcome of the event was unknown. Information on the batch number has been requested.
Information has been received from a nurse practitioner concerning a 34 year old male who was vaccinated with a first and second dose of Varivax in 01/01 and 06/01, respectively. Subsequently the titer drawn after vaccination was negative. The patient was then vaccinated with a third and fourth dose of Varivax on 08/28/01
Bell's Palsy; This spontaneous report has been received from the patient's mother, referring to her son, a 20 years old male patient. Information about medical history, concurrent conditions, concomitant therapies and drug allergies was not provided.       On an unknown date in January 2013, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (lot #: H016960, expiration date reported as December 2013 but upon internal validation established as 02-DEC-2013; route and dose details were unknown) for prophylaxis.         On an unknown date in January 2013, the patient experienced Bell's Palsy after receiving the quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL).      The outcome of the event was not provided. The causality assessment between the event and quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) was not provided.  Upon internal review, Bell's Palsy was determined to be medically significant.
After a few hours, experienced fatigue, dizziness, insomnia, headache that lasted for less than 24 hours.  I felt normal but tired after 24 hours.
Everything they advertised that it is supposed to prevent-is what I ended up with. Horrible cough. Headache. Hard time getting my air. Put on antibiotic 1/4/16. Pneumonia set in.
Extreme pain and swelling of lymph nodes in left breast, then moved into right breast several weeks later. Treated with ibuprofen and icing the area. Visited urgent care initially and wasn't given a clear dx, then later was recommended to seek an ultrasound and mammogram followed by a biopsy. Pain continued off and on for approximately 2 months, then gradually disappeared.
3 1/2" x 3" red induration on right post arm with localized heat and itching. Treatment oral Benadryl and Hydrocortisone cream.
Information has been received from a pharmacist concerning a male who on 10-Sept-2008, was vaccinated with one dose of ZOSTAVAX that was inadvertently reconstituted with PNEUMOVAX. On 12-Sep-2008, follow-up information was received from the pharmacist who reported that the patient experienced mild inflammation at the injection site. The patient's inflammation had improved. It was unknown if the patient sought medical attention. No further information is available.